rays today is TW friday..end of quarter option so volatility will be there often.....BABA bt w is run by jack ma who I like a lott...he cleaned Meg Whitmanns Clock in china when she ytried to make a run w/ ebay..too bad shes a good financier but a lousy judge of National Pride..she could have bought a piece of BABA for maybe 100M a few yrs ago but the GREEDY #$%$ had her sites set on being BHOs Tech tzar!
BHO gets left overs iows!
$5 for BRIL as it is now YES and if the others come thru theres NO telling where she goes....but typically a BB antibiotic can do 1B in sales revs by 3-5 yrs... so U tell me whats its worth?
LOLAY colino..its iggie and if I meet you Ill give U the chance to back your words PUZZY!
Dilivent these financials lead me to believ that at current cash burn they will need to raise more MONEY soon? Thoughts?
[Research and development expenses for the six months ended June 30, 2014 were NIS 8.64 million (U.S. $2.51 million) compared with NIS 7.66 million (U.S. $2.23 million) for the same period in 2013. Research and development expenses for the first half of 2014 comprised primarily of expenses associated with the initiation of a planned Phase II study for CF102 as well as expenses for pre-clinical studies of CF102.General and administrative expenses were NIS 5.42 million (U.S. $1.58 million) for the six months ended June 30, 2014 and NIS 6.59 million (U.S. $1.92 million) for the same period in 2013. The decrease is primarily due to a reduction in share based compensation expenses.Financial income, net for the six months ended June 30, 2014 aggregated NIS 1.71 million (U.S. $0.50 million) compared to financial expenses, net of NIS 0.03 million (U.S. $0.01 million) for the same period in 2013. The increase in financial income, net in the first half of 2014 was mainly due to a decrease in the fair value of the Company's warrants.Can-Fite's loss for the six months ended June 30, 2014 was NIS 12.36 million (U.S. $3.59 million) compared with a loss of NIS 14.29 million (U.S. $4.15 million) for the same period in 2013. The decrease in net loss for the first half of 2014, was attributable to an increase in finance income, net.As of June 30, 2014, Can-Fite had cash and cash equivalents of NIS 19.19 million (U.S. $5.58 million) as compared to NIS 20.77 million (U.S. $6.04 million) at December 31, 2013. The company raised NIS 15.9 million (U.S. $4.62 million) during the first half of 2014. The decrease in cash during that period was due to cash used to finance the operations exceeding the raised amount]
DILIVENT please comment on your thoughts in this company..I may be a buyer..this drug CF102 is intriguing?
Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver RegeneraDtion and Function Following Surgery
September 05, 2014
07:00 AM ET
PETACH TIKVA, Israel, Sept. 5, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the issuance of Patent No. 2010-529501, titled, "Method for inducing hepatocyte proliferation and uses thereof," by the Japanese Patent Office. The patent covers Can-Fite's clinical stage drug candidate, CF102, in the treatment of liver regeneration and function following liver surgery or other injury via inhibition of pro-apoptotic proteins, resulting in liver repair. A European Patent (No. 2227234) for this technology was issued earlier this year in the European Union."This patent further expands our worldwide patent portfolio," stated Dr. Pnina Fishman, CEO of Can-Fite. "In preclinical studies, CF102 induces proliferation of hepatocytes following liver resection (surgery), increases liver weight and reduces elevated levels of serum liver enzymes, reflecting improved liver status. In patients with preexisting liver diseases, such as cirrhosis or cancer, normal hepatocellular proliferation following injury is impaired, exposing patients to liver dysfunction and associated complications that can lead to liver failure and death. We believe that the use of CF102 to induce proliferation of hepatocytes in liver cancer patients following surgery may provide important health benefits and prolong survival."CF101, for the treatment of autoimmune inflammatory indications in Japan.
is this the CANF U are talking about?
I see the connection in psoriasis but not BRIL?
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company's drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang #$%$ Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.
the bears have been saying for 12 months that NO ONE BUT CTIX went to the BK and bid for PYMX..I find that hard to believe but somehow they walked away w/ the BRIL prize....I immediaytely went back into CTIX when I read that news and I paid $2 a share...Ive since kept my CORE adding on all dips and walked her up to 100K shares and only on this last run to $2.47 did I lighten to about 75K shares....stock imo is worth at least double now on BRIL alone!
We need to uplist and it will get there fast!
wow and to think I bought more yesterday at 13.88 in both Sons accts!
RB you will cover by 4:00PM tomorrow as the TW gets your option play...watch CLDX sp go up forcing a mini squeeze tomorrow after a small sell off at the open.....where I buy even more!
U are one smart INVESTOR dilivent!
I admire you and must be honest..I had a 33 year in Antibiotics..it was not hard for me to find these plays and trade these stocks..Ive made a small fortune on them already...my first forrays was into CBST as a spread play and TRSX as atakover candidate and Ive done great w/ both...sorry if the bd thinks Im bragging...its just easy to make MONEY in stocks and I wonder why so mant LOSE so badly..its just DD to me that makes the difference and bUY low and sell High...LOL!
This one CTIX will be a double from here maybe by eoy!
Sentiment: Strong Buy
dude I am one of the RICHEST idiots YOUVE EVER NOT MET and likely will never meet....and Ive make a LIVING trading stocks in RETIREMENT from age 55 to now 62...while your lame #$%$ will work till the day you die likely.
Sentiment: Strong Buy
wow thats an Interesting Question rtw and very thoughtful....BRIL will prove very strong and at a single dose very tolerable too....this antibiotic KILLS QUICKLY and LETHALLY and I suspect since so many may have been asleep at the BK switch when Leo and Menon stole this PYMX asset for $5M....well U cant fire them all! which is still not UPLISTED...so still UNDISCOVERED!
well in the Immortal words of Pres Reagan a POTUS Im sure U know nadda about ..I wont hold your YOUTH against you Son!
Your point is BS and so go away little boy/goyle.....no one is talking about Big Johnsons here..we are talking about RATIONAL TRADING of a PENNY BB stock.....
I still have 75K shares and IM NOT BRAGGING...this is what people do day in day out on message bds..its not my fault that U just learned about CTIX and bought shs probably from me in the $2+ move which I was fortunate to sell into!
Im net $1.05 on all 75K shares now and we KNOW where you are MR CLA$$Y guy...LOLAY!
The fact that I got 10 negs on this tells me ALL OF YOU ARE NEWBIES and thats good.....I hope I cont to offend you all!
giz Im not here to get along Im here to be honest and tell it like it is...I know all the newbies want this to climb to the moon but that is unrealistic and we all know that sooner or later someone who bought shares cheap like me at 1.60 is going to announce they are selling as high as 2.47 the other day!
It might as well be me since I know more about antibiotics than most....its not that I dont belive CTIX will eventually double from here to $5 and Ive stated that it will and maybe by year end too...its just that I have .87 profit now on maybe 25K shares that i was able to buy and thats nothing to SNEEZE over at $21750 so I was gonna sell into this move..the bd can thank me for slowly FEEDING this move as I let shares go gently always PULLING the ASK higher and HIGHER and that has allowed me this exuberance!
Ive since now lowered my CORE HOLDING net cos to $1.05 and I will remind all I came to CTIX at $2 buys 1+ year ago!
good AM LV!
If the data were to be positive or even better... would this alone be enough that CLDX could submit application for earlier use of Rindo.....weve seen this before and we have examples today of cos getting earlier Rx approvals although they are still actively in clinic..some Countries or EMA have even provided earlier approval and reimbursement.....btw congrat$ on the Solvadi expansion and affordability move in the third world!
Im selling some more BMY at 51+ and at a nice profit just on this GILD move!